Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Ergolines (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Ergolines (administration & dosage) < Ergolines (adverse effects) < Ergolines (chemistry)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000B18 (2003) Antje M. Smala [Allemagne] ; E Annika Spottke ; Olaf Machat ; Uwe Siebert ; Dieter Meyer ; Rudolf Köhne-Volland ; Martin Reuther ; Janeen Duchane ; Wolfgang H. Oertel ; Karin B. Berger ; Richard C. DodelCabergoline versus levodopa monotherapy: a decision analysis.
000E40 (2004) Judit Horvath [Suisse] ; Robin D. Fross ; Galit Kleiner-Fisman ; René Lerch ; Hans Stalder ; Suzanne Liaudat ; William J. Raskoff ; Keith D. Flachsbart ; Harry Rakowski ; Jean-Claude Pache ; Pierre R. Burkhard ; Anthony E. LangSevere multivalvular heart disease: a new complication of the ergot derivative dopamine agonists.
000F67 (2004) Katherine Grosset [Royaume-Uni] ; Fiona Needleman ; Graeme Macphee ; Donald GrossetSwitching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
000F82 (2004) Yvonne Körner [Allemagne] ; Charlotte Meindorfner ; Jens Carsten Möller ; Karin Stiasny-Kolster ; Doris Haja ; Werner Cassel ; Wolfgang Hermann Oertel ; Hans-Peter KrügerPredictors of sudden onset of sleep in Parkinson's disease.
001078 (2004) K Ray Chaudhuri ; Vandena Dhawan ; Sumit Basu ; Gordon Jackson ; Per OdinValvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.
001A90 (2007) Claudia Trenkwalder [Allemagne] ; Heike Benes ; Ludger Grote ; Svenja Happe ; Birgit Högl ; Johannes Mathis ; Gerda M. Saletu-Zyhlarz ; Ralf KohnenCabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial.
001D74 (2007) Gregor Simonis [Allemagne] ; Joerg T. Fuhrmann ; Ruth H. StrasserMeta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists.
002101 (2008) Kazuo Yamashiro [Japon] ; Miki Komine-Kobayashi ; Taku Hatano ; Takao Urabe ; Hideki Mochizuki ; Nobutaka Hattori ; Yoshitaka Iwama ; Hiroyuki Daida ; Michi Sakai ; Takeo Nakayama ; Yoshikuni MizunoThe frequency of cardiac valvular regurgitation in Parkinson's disease.
002505 (2009) Frank Andersohn [Allemagne] ; Edeltraut GarbeCardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
002D19 (2010) Alessandro Rotondo ; Domenico Bosco ; Massimiliano Plastino ; Arturo Consoli ; Francesca BoscoClozapine for medication-related pathological gambling in Parkinson disease.
004A50 (1995) R. Inzelberg [Israël] ; P. Nisipeanu ; M J Rabey ; A D KorczynLong-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease.
004A93 (1996) L V Metman [États-Unis] ; P J Blanchet ; D. De Jong ; M M Mouradian ; T N ChaseEffect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease.
004B93 (1996) G. Geminiani [Italie] ; V. Fetoni ; S. Genitrini ; P. Giovannini ; F. Tamma ; T. CaraceniCabergoline in Parkinson's disease complicated by motor fluctuations.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Ergolines (adverse effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Ergolines (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Ergolines (adverse effects)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024